Literature DB >> 11008900

Visual outcome and complications after posterior capsule rupture during phacoemulsification surgery.

E Y Yap1, W J Heng.   

Abstract

PURPOSE: To determine the visual outcome and incidence of complications after posterior capsule rupture during phacoemulsification surgery.
METHODS: Forty-four eyes of 43 patients which sustained posterior capsule rupture or zonulysis during phacoemulsification surgery between April 1993 and May 1996 were retrospectively studied. Eyes With pseudoexfoliation syndrome, traumatic cataract and myopia > 6 dioptres were excluded from the study. The mean postoperative follow-up period was 26 months (range 3 to 47 months).
RESULTS: Forty-one eyes had posterior capsule rupture and 3 eyes had zonulysis. Of these 44 eyes, 41 eyes had vitreous loss and anterior vitrectomy at the time of surgery or subsequently. Excluding 2 eyes with pre-existing conditions that precluded good vision, 36 out of 42 eyes (85.7%) achieved spectacle corrected visual acuity of 6/12 or better post-operatively. Of all 42 eyes, 20 had anterior chamber intraocular lens (ACIOL) implantation while the others had posterior chamber intraocular lens (PCIOL) implantation. For eyes with ACIOL, 17 out of 20 eyes (85.0%) had best corrected visual acuity of 6/12 or better. For eyes with PCIOL, 19 out of 22 eyes (86.4%) had best corrected visual acuity of 6/12 or better.
CONCLUSIONS: Phacoemulsification surgery, even if complicated by posterior capsule rupture or zonulysis, is compatible with good visual outcome. This is provided prompt attention is paid to the management of complications.

Entities:  

Mesh:

Year:  1999        PMID: 11008900     DOI: 10.1023/a:1006462928542

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  8 in total

1.  Visual results and complications of phacoemulsification with intraocular lens implantation performed by ophthalmology residents.

Authors:  O A Cruz; G W Wallace; C A Gay; A Y Matoba; D D Koch
Journal:  Ophthalmology       Date:  1992-03       Impact factor: 12.079

2.  Learning phacoemulsification: the surgeon-in-training.

Authors:  H Tabandeh; B Smeets; M Teimory; H Seward
Journal:  Eye (Lond)       Date:  1994       Impact factor: 3.775

3.  Outcomes of vitrectomy for retained lens fragments.

Authors:  M J Borne; W Tasman; C Regillo; M Malecha; L Sarin
Journal:  Ophthalmology       Date:  1996-06       Impact factor: 12.079

4.  Visual outcome of cataract extraction and lens implantation complicated by vitreous loss.

Authors:  A Balent; L L Civerchia; P Mohamadi
Journal:  J Cataract Refract Surg       Date:  1988-03       Impact factor: 3.351

5.  Visual outcome in pseudophakic eyes with clinical cystoid macular edema.

Authors:  R S Ruiz; O A Saatci
Journal:  Ophthalmic Surg       Date:  1991-04

6.  Are there acceptable anterior chamber intraocular lenses for clinical use in the 1990s? An analysis of 4104 explanted anterior chamber intraocular lenses.

Authors:  G U Auffarth; T A Wesendahl; S J Brown; D J Apple
Journal:  Ophthalmology       Date:  1994-12       Impact factor: 12.079

7.  National outcomes of cataract extraction. I. Retinal detachment after inpatient surgery.

Authors:  J C Javitt; S Vitale; J K Canner; H Krakauer; A M McBean; A Sommer
Journal:  Ophthalmology       Date:  1991-06       Impact factor: 12.079

8.  Posterior capsulorhexis in adult eyes with intact and clear capsules.

Authors:  A Galand; F van Cauwenberge; J Moosavi
Journal:  J Cataract Refract Surg       Date:  1996-05       Impact factor: 3.351

  8 in total
  2 in total

1.  Validation of two scoring systems for the prediction of posterior capsule rupture during phacoemulsification surgery.

Authors:  S A Osborne; W E Adams; C V Bunce; S G Fraser
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

2.  Vitrectomy as a Risk Factor for Complicated Cataract Surgery.

Authors:  Moss J Fenberg; Kenneth J Hainsworth; Frank G Rieger; Dean P Hainsworth
Journal:  Mo Med       Date:  2016 Jan-Feb
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.